|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | ESVS指南:颈动脉狭窄有创性治疗的适应证和技术显示文摘欧洲血管外科学会召集颈动脉疾病领域的专家制定了关于颈动脉疾病有创性治疗的最新指南。根据证据级别对推荐意见进行分级。对于狭窄程度〉50%的有症状患者,如果围手术期卒中/死亡发生率〈6%,则推荐行颈动脉内膜切除术(carotid endarterectomy,CEA)(A级推荐),最好在患者最近发作的2周内进行(A级推荐)。对于狭窄程度为70%~99%并且年龄在75岁以下的男性无症状患者,如果围手术期卒中/死亡发生率〈3%,也推荐行CEA(A级推荐)。女性无症状患者从CEA中获得的益处明显不如男性患者(A级推荐)。因此,只有年龄较小的合适的女性患者才考虑行CEA(A级推荐)。颈动脉补片血管成形术优于直接缝合(A级推荐)。在CEA术前、术中和术后均应给予阿司匹林(75~325medd)和他汀类药物治疗(A级推荐)。颈动脉支架置入术(carotid artery stenting,CAS)仅适用于CEA高危患者,并且应在围手术期卒中,死亡发生率较低的大型中心或是在随机对照试验中进行(C级推荐)。在CAS治疗的同时,应使用阿司匹林+氯吡格雷双重抗血小板治疗(A级推荐)。使用颈动脉保护装置可能有益(C级推荐)。 | C.D. Liapis P.R.F. Bell D. Mikhailidis J. Sixenius A. Nicolaides J. Femandes e Fermndes G. Biasi L. Norgren 无 尧瑶(译) 兰青(译) | 2009 | 国际脑血管病杂志2009，17，5： | 34 |
| 2 | 欧洲血管外科学会指南:第二部分——颈动脉狭窄患者的诊断和检查显示文摘在此,我们呈献颈动脉狭窄患者脑血管事件二级预防的欧洲血管外科学会指南,包括降脂治疗、抗血小板治疗以及其他危险因素控制。这些推荐均基于现有的临床试验证据。对颈动脉病患者需要采取积极的预防性治疗。我们还讨论了颈动脉狭窄的诊断和分级。 | Christos D. Liapis Sir Peter F. Bell Dimitri P. Mikhailidis Juharli Sivenius Andrew Nicolaides Jose Femandes e Fernandes Giorgio Biasi Ears Norgrer 赵颖(译) 谭泽锋(译) 徐安定(译) | 2011 | 国际脑血管病杂志2011，19，7： | 9 |
| 3 | 欧洲血管外科学会指南:第1部分——颈动脉狭窄患者的预防显示文摘在此,我们呈献颈动脉狭窄患者脑血管事件二级预防的欧洲血管外科学会指南,包括降脂治疗、抗血小板治疗以及其他危险因素控制。这些推荐均基于现有的临床试验证据。对颈动脉疾病患者需要采取积极的预防性治疗。我们还讨论了颈动脉狭窄的诊断和分级。 | Christos D. Liapis Sir Peter F. Bell Dimitri P. Mikhailidis Juhani Sivenius Andrew Nicolaides Jose Femandes e Fernandes Giorgio Biasi Lars Norgren 董大伟(译) 刘小艳(译) 徐安定(译) | 2011 | 国际脑血管病杂志2011，19，6： | 7 |
| 4 | The chimney graft technique for preserving visceral vessels during endovascular treatment of aortic pathologies显示文摘 | Konstantinos G. Moulakakis Spyridon N. Mylonas Efthimios Avgerinos Anastasios Papapetrou John D. Kakisis Elias N. Brountzos Christos D. Liapis | 2012 | Journal of Vascular Surgery2012，，5： | 2 |
| 5 | Excellent long term patient and renal allograft survival after ABO-incompatible kidney transplantation:Experience of one center显示文摘AIM: To investigate the long-term results of ABOincompatible(ABOi) kidney transplantation in a single center in Greece.METHODS: Thirty consecutive ABOi kidney transplantations were performed from June 2005 to December 2013. All patients received rituximab one month prior to transplantation. Immunoadsorption therapy was performed for the removal of anti-A/B Ig G antibodies until the titer was ≤ 1:16. Additional apheresis sessions were performed post-operatively. Intravenous immunoglobulin and oral immunosuppression consisting of tacrolimus(TAC) in combination with either everolimus or mycophenolate acid was administered. We compared the long term results of our ABOi group to those of a matched group of 30 ABO compatible(ABOc) living kidney recipients with similar baseline characteristics. The ABOc recipients received an immunosuppressive regimen consisting of TAC and mycophenolate acid. All patients in both groups received induction therapy with Basiliximab or Daclizumab, whereas corticosteroids were instituted on the day of surgery. During the followup period, indication biopsies were performed and interpreted by an experienced nephropathologist. The parameters we analyzed included the following: Donor/recipient age, gender, blood type, human leukocyte antigen mismatches, panel reactive antibodies, primary cause of renal failure, mean time on dialysis, immunosuppressive regimen, patient survival, graft outcome, incidence of rejections, surgical and infectious complications.RESULTS: The mean follow-up period was 6 years(range 1 to 9 years). A mean of 5.0 ± 3.0(range 0-14) pre-transplant immunoadsorptions were required in order to reach the target titer. Patient survival in ABOi group in comparison to ABOc group at 1, 3, 5 and 8 years did not differ significantly(100% vs 100%, 96% vs 100%, 92% vs 100% and 92% vs 100%, P = ns). Additionally, graft survival was similar in the two groups at the same time points(100% vs 100%, 96% vs 96%, 92% vs 96% and 81% vs 92%, P = ns). The mean serum creatinine and the estimated glomerular filtration rate by the modification of diet in renal disease formula at 1, 3, 5 and 8 years did not differ significantly between ABOi and ABOc group. None of the patients in the ABOi group developed acute or chronic antibodymediated rejection evidenced by histological signs. Four patients(13.3%) in the ABOi group and 3(10%) in the ABOc group experienced acute cellular rejection, which was treated successfully in all cases. Bacterial and viral infections were also similar between the two groups.CONCLUSION: ABOi kidney transplantation is a safe and effective alternative that enables kidney transplantation in countries with unacceptably long deceaseddonor waiting lists. | Christina Melexopoulou Smaragdi Marinaki George Liapis Chrysanthi Skalioti Maria Gavalaki George Zavos John N Boletis | 2015 | World Journal of Transplantation2015，5，4： | 2 |
| 6 | Changes in the quantity of collagen type Ⅰ in women with genuine stress incontinence显示文摘 | Bakas P Liapis A Pafiti A | 2000 | Urol res2000，28，5： | 1 |
| 7 | Carotid stenosis:fac-tors affecting symptomatology显示文摘 | Liapis C D Kakisis J D Kostakis A G | 2001 | Stroke2001，32，12： | 1 |
| 8 | Changes in the quantity of collagen type Ⅰ in women with genuine stress incontinence显示文摘 | LIAPIS A BAKAS P PAFITI A | 2000 | Urol Res2000，28，5： | 1 |
| 9 | Is ceftriaxone-induced biliary pseudolithiasis influenced by UDP-glucuronosyltransferase1A1gene polymorphisms显示文摘 | Fretzayas A Liapi O Papadopoulou A Nicolaidou P Stamoulakatou A | 2011 | Case Report Med2011，2011，73： | 1 |
| 10 | Considerations for implan- tation site of VX2 carcinoma into rabbit liver 显示文摘 | Lee KH Liapi E Buijs M | 2009 | J Vase Interv Radiol2009，20，1： | 1 |
| 11 | Assessment of tumoricidal efficacy and response to treatment with 18F -FOG PET/CT after in?traarterial infusion with the antiglycolytic agent 3-bromopyruvate in the VX2 model of liver tumor显示文摘 | Liapi E GeschwindJF Vali M | 2011 | J Nucl Med2011，52，2： | 1 |
| 12 | Changes of collagen type Ⅲ in female patients with genuine stress incontinence and pelvic floor prolapse 显示文摘 | Bakas P Liapis A Pafiti A | 2001 | Eur J Obstet Gynecol Reprod Boil2001，97，8： | 1 |
| 13 | Tension-free vaginal tape versus tension-free vaginal tape obturator in women with stress urinary incontinence显示文摘 | Liapis A Bakas P Giner M | 2006 | Gynecol Obstet Invest2006，62，3： | 1 |
| 14 | mRNA assessment for procollagen production in women with genuine stress urinary incontinence显示文摘 | BAKAS PG LIAPIS A E ZERVOLEA I | 2004 | Int Urogynecol J Pelvic Floor Dysfunct2004，15，6： | 1 |
| 15 | Inflammation and Chlamydia pneumoniae infection correlate with the severity of peripheral arterial disease显示文摘 | KAPERONIS E A LIAPIS C D KAKISIS J D | 2006 | Eur J Vasc Endovasc Surg2006，31，： | 1 |
| 16 | Hemolysis in Wilson' s disease显示文摘 | Liapis K Charitaki E Delimpasi S | | Annals of Hematology0，，： | 1 |
| 17 | Glomerular injury associated with hepatitis C infection: A correlation with blood and tissue HCV-PCR显示文摘 | Hoch B Juknevicius I Liapis H | 2002 | Semin Diagn Pathol2002，19，3： | 1 |
| 18 | Cer-ebral aspergillosis显示文摘 | LIAPIS K MAN AKA K BALTADAKIS I | 2009 | Eur J Haematol2009，82，： | 1 |
| 19 | Primitive neuroectodermal tumorof the kidney-another enigma:a pathologic,immunohistochemical,and molecular diagnostic study显示文摘 | Marley EF Liapis H Humphrey PA | 1997 | Am J Surg Pathol1997，21，3： | 1 |
| 20 | Integrin alpha V beta 3 expression by bone-residing breast cancer metastases显示文摘 | Liapis H Flath A Kitazawa S | 1996 | Diagn Mol Pathol1996，5，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员